References
- Fukui T, Mori S, Hatooka S, Shinoda M, Mitsudomi T. Prognostic evaluation based on a new TNM staging system proposed by the International Association for the Study of Lung Cancer for resected non-small cell lung cancers. J. Thorac. Cardiovasc. Surg.136(5), 1343–1348 (2008).
- Yamashita K, Sakuramoto S, Kikuchi S, Katada N, Kobayashi N, Watanabe M. Validation of staging systems for gastric cancer. Gastric Cancer11(2), 111–118 (2008).
- Merkel S, Bialecki D, Meyer T, Muller V, Papadopoulos T, Hohenberger W. Comparison of clinical risk scores predicting prognosis after resection of colorectal liver metastases. J. Surg. Oncol.100(5), 349–357 (2009).
- Choi SB, Lee JG, Kim KS et al. The prognosis and survival analysis according to seven staging systems of hepatocellular carcinoma following curative resection. Hepatogastroenterology55(88), 2140–2145 (2008).
- Kayahara M, Nagakawa T, Nakagawara H, Kitagawa H, Ohta T. Prognostic factors for gallbladder cancer in Japan. Ann. Surg.248(5), 807–814 (2008).
- Wijnhoven BP, Tran KT, Esterman A, Watson DI, Tilanus HW. An evaluation of prognostic factors and tumor staging of resected carcinoma of the esophagus. Ann. Surg.245(5), 717–725 (2007).
- Dobbin K, Simon R. Sample size determination in microarray experiments for class comparison and prognostic classification. Biostatistics6(1), 27–38 (2005).
- Yang Y, Pospisil P, Iyer LK, Adelstein SJ, Kassis AI. Integrative genomic data mining for discovery of potential blood-borne biomarkers for early diagnosis of cancer. PLoS ONE3(11), E3661 (2008).
- Ioannidis JP, Allison DB, Ball CA et al. Repeatability of published microarray gene expression analyses. Nat. Genet.41(2), 149–155 (2009).
- Omenn GS, States DJ, Adamski M et al. Overview of the HUPO Plasma Proteome Project: results from the pilot phase with 35 collaborating laboratories and multiple analytical groups, generating a core dataset of 3020 proteins and a publicly-available database. Proteomics5(13), 3226–3245 (2005).
- Gong Y, Li X, Yang B et al. Different immunoaffinity fractionation strategies to characterize the human plasma proteome. J. Proteome Res.5(6), 1379–1387 (2006).
- Anderson NL, Polanski M, Pieper R et al. The human plasma proteome: a nonredundant list developed by combination of four separate sources. Mol. Cell. Proteomics3(4), 311–326 (2004).
- Service RF. Proteomics. Proteomics ponders prime time. Science321(5897), 1758–1761 (2008).
- O’Farrell PH. High resolution two-dimensional electrophoresis of proteins. J. Biol. Chem.250(10), 4007–4021 (1975).
- Klose J. Protein mapping by combined isoelectric focusing and electrophoresis of mouse tissues. A novel approach to testing for induced point mutations in mammals. Humangenetik26(3), 231–243 (1975).
- Strahler JR, Hanash SM, Somerlot L, Weser J, Postel W, Gorg A. High resolution two-dimensional polyacrylamide gel electrophoresis of basic myeloid polypeptides: use of immobilized pH gradients in the first dimension. Electrophoresis8(4), 165–173 (1987).
- Righetti PG. Immobilized pH Gradients: Theory and Methodology. Burdon RH, van Knippenberg PH (Eds). Elsevier, Amsterdam, The Netherlands (1990).
- Sabounchi-Schutt F, Astrom J, Olsson I, Eklund A, Grunewald J, Bjellqvist B. An immobiline DryStrip application method enabling high-capacity two-dimensional gel electrophoresis. Electrophoresis21(17), 3649–3656 (2000).
- Sanchez JC, Rouge V, Pisteur M et al. Improved and simplified in-gel sample application using reswelling of dry immobilized pH gradients. Electrophoresis18(3–4), 324–327 (1997).
- Gorg A, Obermaier C, Boguth G, Weiss W. Recent developments in two-dimensional gel electrophoresis with immobilized pH gradients: wide pH gradients up to pH 12, longer separation distances and simplified procedures. Electrophoresis20(4–5), 712–717 (1999).
- Gelfi C, Morelli A, Rovida E, Righetti PG. pH measurements in ultranarrow immobilized pH gradients. J. Biochem. Biophys. Methods13(2), 113–124 (1986).
- Unlu M, Morgan ME, Minden JS. Difference gel electrophoresis: a single gel method for detecting changes in protein extracts. Electrophoresis18(11), 2071–2077 (1997).
- Kondo T, Hirohashi S. Application of highly sensitive fluorescent dyes (CyDye DIGE Fluor saturation dyes) to laser microdissection and two-dimensional difference gel electrophoresis (2D-DIGE) for cancer proteomics. Nat. Protoc.1(6), 2940–2956 (2007).
- Shaw J, Rowlinson R, Nickson J et al. Evaluation of saturation labelling two-dimensional difference gel electrophoresis fluorescent dyes. Proteomics3(7), 1181–1195 (2003).
- Kondo T, Seike M, Mori Y, Fujii K, Yamada T, Hirohashi S. Application of sensitive fluorescent dyes in linkage of laser microdissection and two-dimensional gel electrophoresis as a cancer proteomic study tool. Proteomics3(9), 1758–1766 (2003).
- Rabilloud T. Use of thiourea to increase the solubility of membrane proteins in two-dimensional electrophoresis. Electrophoresis19(5), 758–760 (1998).
- Taylor RS, Wu CC, Hays LG, Eng JK, Yates JR 3rd, Howell KE. Proteomics of rat liver Golgi complex: minor proteins are identified through sequential fractionation. Electrophoresis21(16), 3441–3459 (2000).
- Westbrook JA, Yan JX, Wait R, Welson SY, Dunn MJ. Zooming-in on the proteome: very narrow-range immobilised pH gradients reveal more protein species and isoforms. Electrophoresis22(14), 2865–2871 (2001).
- Poland J, Cahill MA, Sinha P. Isoelectric focusing in long immobilized pH gradient gels to improve protein separation in proteomic analysis. Electrophoresis24(7–8), 1271–1275 (2003).
- Zhan X, Desiderio DM. A reference map of a human pituitary adenoma proteome. Proteomics3(5), 699–713 (2003).
- Liang RC, Neo JC, Lo SL, Tan GS, Seow TK, Chung MC. Proteome database of hepatocellular carcinoma. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci.771(1–2), 303–328 (2002).
- Cho SY, Park KS, Shim JE et al. An integrated proteome database for two-dimensional electrophoresis data analysis and laboratory information management system. Proteomics2(9), 1104–1113 (2002).
- Fujii K, Kondo T, Yokoo H et al. Database of two-dimensional polyacrylamide gel electrophoresis of proteins labeled with CyDye DIGE Fluor saturation dye. Proteomics6(5), 1640–1653 (2006).
- Li F, Xiao Z, Zhang P et al. A reference map of human nasopharyngeal squamous carcinoma proteome. Int. J. Oncol.30(5), 1077–1088 (2007).
- Li F, Li M, Xiao Z, Zhang P, Li J, Chen Z. Construction of a nasopharyngeal carcinoma 2D/MS repository with open source XML database – Xindice. BMC Bioinformatics7, 13 (2006).
- Oh JM, Brichory F, Puravs E et al. A database of protein expression in lung cancer. Proteomics1(10), 1303–1319 (2001).
- Mori Y, Kondo T, Yamada T, Tsuchida A, Aoki T, Hirohashi S. Two-dimensional electrophoresis database of fluorescence-labeled proteins of colon cancer cells. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci.823(2), 82–97 (2005).
- Hanash SM, Teichroew D. Mining the human proteome: experience with the human lymphoid protein database. Electrophoresis19(11), 2004–2009 (1998).
- Traxler E, Bayer E, Stockl J, Mohr T, Lenz C, Gerner C. Towards a standardized human proteome database: quantitative proteome profiling of living cells. Proteomics4(5), 1314–1323 (2004).
- Fujii K, Kondo T, Yamada M, Iwatsuki K, Hirohashi S. Toward a comprehensive quantitative proteome database: protein expression map of lymphoid neoplasms by 2-D DIGE and MS. Proteomics6(17), 4856–4876 (2006).
- Chen G, Gharib TG, Huang CC et al. Discordant protein mRNA expression in lung adenocarcinomas. Mol. Cell. Proteomics1(4), 304–313 (2002)
- Nishizuka S, Charboneau L, Young L et al. Proteomic profiling of the NCI-60 cancer cell lines using new high-density reverse-phase lysate microarrays. Proc. Natl Acad. Sci. USA100(24), 14229–14234 (2003).
- Shankavaram UT, Reinhold WC, Nishizuka S et al. Transcript and protein expression profiles of the NCI-60 cancer cell panel: an integromic microarray study. Mol. Cancer Ther.6(3), 820–832 (2007).
- Yamada M, Fujii K, Koyama K, Hirohashi S, Kondo T. The proteomic profile of pancreatic cancer cell lines corresponding to carcinogenesis and metastasis. J. Proteomics Bioinform.2, 1–18 (2009).
- Uemura N, Nakanishi Y, Kato H et al. Transglutaminase 3 as a prognostic biomarker in esophageal cancer revealed by proteomics. Int. J. Cancer124(9), 2106–2115 (2009).
- Kikuta K, Tochigi N, Shimoda T et al. Nucleophosmin as a candidate prognostic biomarker of Ewing’s sarcoma revealed by proteomics. Clin. Cancer Res.15(8), 2885–2894 (2009).
Websites
- GeMDBJ Proteome Database version 1.2 https://gemdbj.nibio.go.jp/dgdb/dige/servlet/DigeLinkTo2dDatabaseServlet
- SWISS-2D-PAGE www.expasy.ch/ch2d
- SIENA-2D-PAGE www.bio-mol.unisi.it/2d/2d.html
- DOSAC-COBS 2D Page www.dosac.unipa.it/cgi-bin/2d/2d.cgi
- The Make2D-DB II Package version: 2.50.1 www.expasy.ch/ch2d/make2ddb
- The Open2Dprot Project for n-Dimensional Protein Expression Data Analysis http://Open2Dprot.sourceforge.net
- Genome Medicine Database of Japan Proteomics (GeMDBJ Proteomics) http://gemdbj.nibio.go.jp/dgdb/DigeTop.do
- GeMDBJ public release #3.8 13 November 2009 https://gemdbj.nibio.go.jp/dgdb
- H-Invitational Database (H-InvDB) www.h-invitational.jp
- UniProt Database www.uniprot.org